Wuhan Tiandakang Biotech Engineering

Wuhan Tiandakang Biotech Engineering is a Chinese biotechnology company specializing in the research, development, and manufacture of recombinant protein drugs. The company is best known for its production of Recombinant Human Interferon α2b, which is marketed in various formulations including injections, creams, and sprays for treating viral diseases and certain cancers. Based in Wuhan, it operates as a subsidiary of Hubei Biocause Pharmaceutical and maintains GMP-certified manufacturing facilities. Its product portfolio focuses on anti-viral and immunomodulatory therapies, providing essential treatments for conditions such as Hepatitis B and C. The company has established a significant presence in the domestic market for biological therapeutics since its founding in 1993.